Article
Thymidylate synthase disruption to limit cell proliferation in cell therapies
12 Jun 2024
Abstract excerpt
Stem and progenitor cells hold great promise for regenerative medicine and gene therapy approaches. However, transplantations of living cells entail a fundamental risk of unwanted growth, potentially exacerbated by CRISPR-Cas9 or other genetic manipulations. Here, we describe a safety system to control cell proliferation while allowing robust and efficient cell manufacture, without any added genetic elements....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
